Take Advantage of OA Benefits
FinELib licence agreements for scholarly journals include open access benefits. They enable the corresponding authors to publish their articles openly, either free of article processing charges or with a discounted price.
Terms under which the benefits are available and the processes of the publishers vary.
The benefits agreed are listed below. More information is available from your own library or information service.
Instructions to the Corresponding Author
The agreement between FinELib and Taylor & Francis gives the researchers of the subscribing member organisations an opportunity to publish a limited amount of articles open access without additional payment in the Taylor & Francis Open Select standard rate journals and in the Open Access journal Annals of Medicine.Read more
Take advantage of
open access benefits
During negotiations, open access benefits have been agreed upon regarding the journals of the following publishers:
American Chemical Society | Elsevier | Emerald | IEEE | Oxford University Press | Royal Society of Chemistry | Sage | Science Advances | Springer Nature | Taylor & Francis | Wiley | Wolters Kluwer/Lippincott
More information about publisher- and organisation-specific open access benefits is also available from your own library.